Monthly Report - November 2021

Comments:
November 2021 was not a great month for my funds (-0.8%) mainly due to the poor performance of the Hang Seng. The poor earning results by local Chinese tech juggernauts (due to regulatory crackdown) battered the index down to -3% territories. In the 4th week of the month, the announcement of the new COVID variant (Omicron) further brought the index down to its knees (-7.1%). The S&P500 (-0.8%) wasn't as badly affected by the new variant as the US stocks had better earning results. 
   As a result of the poor Hang Seng performance, all my Asian funds also got affected i.e. United ASEAN (-4.0%), Manulife APAC REIT (-2.0%), Principal Greater China (-1.2%) and StashAway (-0.9%). Even my US-heavy fund, the United Global (-2.0%) could not escape the underperformance of the Hang Seng. I do have to be happy that none of my funds dipped to Hang Seng's -7.1% levels. 
   TA Global Tech (+1.6%) was the only fund that ended up in the positive territory this month but it did not managed to beat its benchmark (XLK ETF +4.61%). This fund has not been doing very well against its benchmark in the past few months since i started investing in it.
   Another consolation is my emergency funds in AmBond (+0.5%) did move towards the positive direction.

Forward Strategy:
I will continue to Value Cost Average (VCA) into my funds, keeping them at a fixed weightage as follows; United Global Equity (20.0%), StashAway (20.0%), TA Global Tech (20.0%), Principal Greater China (15.0%), United ASEAN (12.5%) and Manulife REITS (12.5%).